San Francisco Bay Area biotech stories.
Thursday, November 1, 2012
Advanced Cell Diagnostics lines up $12M Series B round
Diagnostic test developer Advanced Cell Diagnostics Inc. completed a $12 million Series B financing, led by New Leaf Venture Partners
The Hayward company, which developed its RNAscope technology to detect and quantify RNA biomarkers, said existing investor Morningside Ventures also participated in the round.
Share to Twitter
Share to Facebook
Share to Pinterest
Advanced Cell Diagnostics
New Leaf Venture Partners
Post a Comment
Post Comments (Atom)